1-6 of 6
Frank Keller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pembrolizumab (pembro) in Children and Young Adults with Low-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Early Results from the Phase 2 Keynote-667 Study

Lisa Giulino Roth, Frank Keller, Mario Melgar Toledo, Sharon M. Castellino, Christopher J. Forlenza, Maitane Andión Catalan, Julie Krystal, Adam Lamble, Aarati V. Rao, Fabio Molina Morales, Stacy Cooper, Flavio Luisi, Oscar Gonzalez Llano, Karla Alejandra Lopez, Christine Mauz-Koerholz, Bradford Hoppe, Juan Shen, Pallavi Pillai, Patricia Marinello, Kara M. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 1700.
https://doi.org/10.1182/blood-2023-186719
Published: 2023
Journal Articles

Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826

Sharon M. Castellino, Hongli Li, Alex F. Herrera, Angela Punnett, Michael Leblanc, Susan K Parsons, David Hodgson, Frank Keller, Richard A. Drachtman, Adam Lamble, Christopher J. Forlenza, Andrew Doan, Sarah C. Rutherford, Andrew M Evens, Richard F. Little, Malcolm A. Smith, Joo Y Song, Sonali M. Smith, Jonathan W. Friedberg, Kara M. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 610.
https://doi.org/10.1182/blood-2023-180107
Published: 2023
Journal Articles

AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Tara O. Henderson, Boyu Hu, Frank Keller, Qinglin Pei, Yue Wu, Bradford Hoppe, Sarah Milgrom, Song Yao, Niloufer Khan, Lisa Giulino Roth, Raymond Mailhot, Steve Cho, Susan K Parsons, Justine M. Kahn, Adam S Duvall, Pamela S. Hinds, Ann LaCasce, Natalie S. Grover, Pamela B. Allen, Andrew M Evens, Heiko Schoder, Sharon M. Castellino, Kara M. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 3084.
https://doi.org/10.1182/blood-2023-189652
Published: 2023
Journal Articles

Pembrolizumab (pembro) in Children and Young Adults with High-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Updated Results from the Phase 2 Keynote-667 Study

Christine Mauz-Koerholz, Auke Beishuizen, Luciana Vinti, Antony Ceraulo, Gerard Michel, Michaela Cepelova, Franca Fagioli, Constantino Sabado Alvarez, Stephane Ducassou, Salvatore Buffardi, Maitane Andión Catalan, Brad Hoppe, Frank Keller, Kara M. Kelly, Lisa Giulino Roth, Judith Landman-Parker, Juan Shen, Pallavi Pillai, Stephen Daw
Journal: Blood
Blood (2023) 142 (Supplement 1): 3063.
https://doi.org/10.1182/blood-2023-187028
Published: 2023
Journal Articles

Longitudinal Differences By Treatment Arm in Health-Related Quality of Life Among High Risk Pediatric Hodgkin's Lymphoma Patients Treated on the Children's Oncology Group Ahod 1331 Study

Annalynn M Williams, Angie Mae Rodday, Qinglin Pei, Tara O. Henderson, Frank Keller, Angela Punnett, Kara M. Kelly, Sharon M. Castellino, Susan K Parsons
Journal: Blood
Blood (2023) 142 (Supplement 1): 672.
https://doi.org/10.1182/blood-2023-187125
Published: 2023
Journal Articles

Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials

Justine M. Kahn, MD, Kara M. Kelly, MD, Qinglin Pei, PhD, Debra L. Friedman, MD, Frank Keller, MD, Rizvan Bush, MS, Smita Bhatia, MDMPH, Tara O. Henderson, MD MPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 607.
https://doi.org/10.1182/blood.V130.Suppl_1.607.607
Published: 2017